Search Results

Press Releases

Rakovina Therapeutics to Participate in BioInnovate UBC Annual Conference

January 29, 2025

·

5 min read

Press Releases

Vir Biotechnology Enrolls First Patient in Phase 3 ECLIPSE Registrational Program for Chronic Hepatitis Delta

March 13, 2025

·

9 min read

Pharm Country

Nikon introduces the SI-PH Phase Condenser accessory option for the ECLIPSE Si biological microscope

Nikon Instruments Inc. (Nikon) has developed the SI-PH Phase Condenser, for dedicated use with the ECLIPSE Si biological microscope, improving the efficiency of the ECLIPSE SI.

May 28, 2024

·

5 min read

Press Releases

New Orleans BioInnovation Center announces winners for BioChallenge pitch competition

November 1, 2024

·

1 min read

Drug Development

Curium Completes Patient Enrollment of Phase 3 ECLIPSE Trial Ahead of Schedule

Curium, a global leader in nuclear medicine, announced the successful completion of patient enrollment in the pivotal Phase 3 ECLIPSE trial.

November 23, 2023

·

2 min read

Limited resources, profit distribution, resource sharing concept. Three hands with forks and one pie chart. Minimalist collage

GLP-1

Lilly, Novo Skew Overall Pharma Trends With Colossal GLP-1 Sales Growth

From revenue to R&D investment, Novo and Lilly and their mega-blockbuster weight loss drugs Zepbound and Wegovy have moved into a new pharma stratosphere, far eclipsing their rivals.

February 12, 2025

·

2 min read

·

Annalee Armstrong

Press Releases

Curium Announces ECLIPSE Trial Has Met Primary Endpoint, Demonstrating a Statistically Significant and Clinically Meaningful Benefit for Patients With PSMA-Positive Metastatic Castration Resistant Prostate Cancer

November 14, 2024

·

2 min read

Drug Development

Eclipse Life Sciences Initiates Phase 2 Study for Novel Ophthalmology Steroid Implant for Diabetic Macular Edema (DME)

August 12, 2024

·

3 min read

Biotech Bay

Guardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of Medicine

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that results from the ECLIPSE study showing the effectiveness of its ShieldTM blood test for detecting colorectal cancer (CRC) in average-risk adults will be published in the March 14 issue of The New England Journal of Medicine.

March 13, 2024

·

10 min read

Press Releases

Genetic Disorders Market Size Set to Eclipse US$ 50.61 Billion by 2033

August 7, 2024

·

14 min read